APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucella Melitensis Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Brucella Melitensis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025183 pages

Choose your research edition.

Industry ResearchBrucella Melitensis Vaccine Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucella Melitensis Vaccine Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Brucella Melitensis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucella Melitensis Vaccine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucella Melitensis Vaccine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Brucella Melitensis Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Brucella Melitensis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Brucella Melitensis Vaccine include Jinyu, VETAL Animal Health Products Inc., Onderstepoort, MSD Animal Health, JOVAC, Hester Biosciences Limited, Dollvet, CZ Veterinaria and Antigen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Brucella Melitensis Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Brucella Melitensis Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brucella Melitensis Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Brucella Melitensis Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Brucella Melitensis Vaccine Segment by Company

Jinyu

VETAL Animal Health Products Inc.

Onderstepoort

MSD Animal Health

JOVAC

Hester Biosciences Limited

Dollvet

CZ Veterinaria

Antigen

Brucella Melitensis Vaccine Segment by Type

Live Vaccines

Attenuated Vaccines

Brucella Melitensis Vaccine Segment by Application

Commercial Farming Enterprise

Private Farming

Brucella Melitensis Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucella Melitensis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucella Melitensis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucella Melitensis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Brucella Melitensis Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Brucella Melitensis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Brucella Melitensis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Brucella Melitensis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Brucella Melitensis Vaccine Industry Trends Table 2. Brucella Melitensis Vaccine Industry Drivers Table 3. Brucella Melitensis Vaccine Industry Opportunities and Challenges Table 4. Brucella Melitensis Vaccine Industry Restraints Table 5. Global Brucella Melitensis Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Brucella Melitensis Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Brucella Melitensis Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Brucella Melitensis Vaccine Sales Market Share by Manufacturers Table 9. Global Brucella Melitensis Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Brucella Melitensis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Brucella Melitensis Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Brucella Melitensis Vaccine Manufacturers, Product Type & Application Table 13. Global Brucella Melitensis Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Brucella Melitensis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Live Vaccines Table 17. Major Manufacturers of Attenuated Vaccines Table 18. Global Brucella Melitensis Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Brucella Melitensis Vaccine Sales by Type (2021-2026) & (k units) Table 20. Global Brucella Melitensis Vaccine Sales by Type (2027-2032) & (k units) Table 21. Global Brucella Melitensis Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Brucella Melitensis Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Brucella Melitensis Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Brucella Melitensis Vaccine Revenue by Type (2021-2026) & (k units) Table 25. Global Brucella Melitensis Vaccine Revenue by Type (2027-2032) & (k units) Table 26. Global Brucella Melitensis Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Brucella Melitensis Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Commercial Farming Enterprise Table 29. Major Manufacturers of Private Farming Table 30. Global Brucella Melitensis Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Brucella Melitensis Vaccine Sales by Application (2021-2026) & (k units) Table 32. Global Brucella Melitensis Vaccine Sales by Application (2027-2032) & (k units) Table 33. Global Brucella Melitensis Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Brucella Melitensis Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Brucella Melitensis Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Brucella Melitensis Vaccine Revenue by Application (2021-2026) & (k units) Table 37. Global Brucella Melitensis Vaccine Revenue by Application (2027-2032) & (k units) Table 38. Global Brucella Melitensis Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Brucella Melitensis Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Brucella Melitensis Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Brucella Melitensis Vaccine Sales by Region (2021-2026) & (k units) Table 42. Global Brucella Melitensis Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Brucella Melitensis Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Brucella Melitensis Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Brucella Melitensis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Brucella Melitensis Vaccine Sales by Country (2021-2026) & (k units) Table 47. North America Brucella Melitensis Vaccine Sales by Country (2027-2032) & (k units) Table 48. Europe Brucella Melitensis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Brucella Melitensis Vaccine Sales by Country (2021-2026) & (k units) Table 50. Europe Brucella Melitensis Vaccine Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Brucella Melitensis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Brucella Melitensis Vaccine Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Brucella Melitensis Vaccine Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Brucella Melitensis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Brucella Melitensis Vaccine Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Brucella Melitensis Vaccine Sales by Country (2027-2032) & (k units) Table 57. Global Brucella Melitensis Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Brucella Melitensis Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Brucella Melitensis Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Brucella Melitensis Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Brucella Melitensis Vaccine Revenue Market Share by Region (2027-2032) Table 62. Jinyu Company Information Table 63. Jinyu Business Overview Table 64. Jinyu Brucella Melitensis Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Jinyu Brucella Melitensis Vaccine Product Portfolio Table 66. Jinyu Recent Development Table 67. VETAL Animal Health Products Inc. Company Information Table 68. VETAL Animal Health Products Inc. Business Overview Table 69. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product Portfolio Table 71. VETAL Animal Health Products Inc. Recent Development Table 72. Onderstepoort Company Information Table 73. Onderstepoort Business Overview Table 74. Onderstepoort Brucella Melitensis Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Onderstepoort Brucella Melitensis Vaccine Product Portfolio Table 76. Onderstepoort Recent Development Table 77. MSD Animal Health Company Information Table 78. MSD Animal Health Business Overview Table 79. MSD Animal Health Brucella Melitensis Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. MSD Animal Health Brucella Melitensis Vaccine Product Portfolio Table 81. MSD Animal Health Recent Development Table 82. JOVAC Company Information Table 83. JOVAC Business Overview Table 84. JOVAC Brucella Melitensis Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. JOVAC Brucella Melitensis Vaccine Product Portfolio Table 86. JOVAC Recent Development Table 87. Hester Biosciences Limited Company Information Table 88. Hester Biosciences Limited Business Overview Table 89. Hester Biosciences Limited Brucella Melitensis Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Hester Biosciences Limited Brucella Melitensis Vaccine Product Portfolio Table 91. Hester Biosciences Limited Recent Development Table 92. Dollvet Company Information Table 93. Dollvet Business Overview Table 94. Dollvet Brucella Melitensis Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Dollvet Brucella Melitensis Vaccine Product Portfolio Table 96. Dollvet Recent Development Table 97. CZ Veterinaria Company Information Table 98. CZ Veterinaria Business Overview Table 99. CZ Veterinaria Brucella Melitensis Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. CZ Veterinaria Brucella Melitensis Vaccine Product Portfolio Table 101. CZ Veterinaria Recent Development Table 102. Antigen Company Information Table 103. Antigen Business Overview Table 104. Antigen Brucella Melitensis Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Antigen Brucella Melitensis Vaccine Product Portfolio Table 106. Antigen Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Brucella Melitensis Vaccine Distributors List Table 110. Brucella Melitensis Vaccine Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Brucella Melitensis Vaccine Product Image Figure 2. Global Brucella Melitensis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brucella Melitensis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Brucella Melitensis Vaccine Sales (2021-2032) & (k units) Figure 5. Global Brucella Melitensis Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Brucella Melitensis Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Live Vaccines Image Figure 9. Attenuated Vaccines Image Figure 10. Global Brucella Melitensis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Brucella Melitensis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Brucella Melitensis Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Brucella Melitensis Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Brucella Melitensis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Brucella Melitensis Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Commercial Farming Enterprise Image Figure 17. Private Farming Image Figure 18. Global Brucella Melitensis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Brucella Melitensis Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Brucella Melitensis Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Brucella Melitensis Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Brucella Melitensis Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Brucella Melitensis Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Brucella Melitensis Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Brucella Melitensis Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Brucella Melitensis Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Brucella Melitensis Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Brucella Melitensis Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Brucella Melitensis Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Brucella Melitensis Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Brucella Melitensis Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Brucella Melitensis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Brucella Melitensis Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Brucella Melitensis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Brucella Melitensis Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Brucella Melitensis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Brucella Melitensis Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Brucella Melitensis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Brucella Melitensis Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Brucella Melitensis Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Attenuated Vaccines
Applications
  • Commercial Farming Enterprise
  • Private Farming
Companies covered
  • Jinyu
  • VETAL Animal Health Products Inc.
  • Onderstepoort
  • MSD Animal Health
  • JOVAC
  • Hester Biosciences Limited
  • Dollvet
  • CZ Veterinaria
  • Antigen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Brucella Melitensis Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Brucella Melitensis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Brucella Melitensis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Brucella Melitensis Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Brucella Melitensis Vaccine Market Dynamics
  1. 2.1 Brucella Melitensis Vaccine Industry Trends
  2. 2.2 Brucella Melitensis Vaccine Industry Drivers
  3. 2.3 Brucella Melitensis Vaccine Industry Opportunities and Challenges
  4. 2.4 Brucella Melitensis Vaccine Industry Restraints
3 Brucella Melitensis Vaccine Market by Manufacturers
  1. 3.1 Global Brucella Melitensis Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Brucella Melitensis Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Brucella Melitensis Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Brucella Melitensis Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Brucella Melitensis Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Brucella Melitensis Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Brucella Melitensis Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Brucella Melitensis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Brucella Melitensis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Brucella Melitensis Vaccine Tier 1, Tier 2, and Tier 3
4 Brucella Melitensis Vaccine Market by Type
  1. 4.1 Brucella Melitensis Vaccine Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Attenuated Vaccines
  4. 4.2 Global Brucella Melitensis Vaccine Sales by Type
  5. 4.2.1 Global Brucella Melitensis Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Brucella Melitensis Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Brucella Melitensis Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Brucella Melitensis Vaccine Revenue by Type
  9. 4.3.1 Global Brucella Melitensis Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Brucella Melitensis Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Brucella Melitensis Vaccine Revenue Market Share by Type (2021-2032)
5 Brucella Melitensis Vaccine Market by Application
  1. 5.1 Brucella Melitensis Vaccine Application Introduction
  2. 5.1.1 Commercial Farming Enterprise
  3. 5.1.2 Private Farming
  4. 5.2 Global Brucella Melitensis Vaccine Sales by Application
  5. 5.2.1 Global Brucella Melitensis Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Brucella Melitensis Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Brucella Melitensis Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Brucella Melitensis Vaccine Revenue by Application
  9. 5.3.1 Global Brucella Melitensis Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Brucella Melitensis Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Brucella Melitensis Vaccine Revenue Market Share by Application (2021-2032)
6 Global Brucella Melitensis Vaccine Sales by Region
  1. 6.1 Global Brucella Melitensis Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brucella Melitensis Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Brucella Melitensis Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Brucella Melitensis Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Brucella Melitensis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Brucella Melitensis Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Brucella Melitensis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Brucella Melitensis Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Brucella Melitensis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Brucella Melitensis Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Brucella Melitensis Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Brucella Melitensis Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Brucella Melitensis Vaccine Revenue by Region
  1. 7.1 Global Brucella Melitensis Vaccine Revenue by Region
  2. 7.1.1 Global Brucella Melitensis Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Brucella Melitensis Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Brucella Melitensis Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Brucella Melitensis Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Brucella Melitensis Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Brucella Melitensis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Brucella Melitensis Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Brucella Melitensis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Brucella Melitensis Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Brucella Melitensis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Brucella Melitensis Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Brucella Melitensis Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Jinyu
  2. 8.1.1 Jinyu Company Information
  3. 8.1.2 Jinyu Business Overview
  4. 8.1.3 Jinyu Brucella Melitensis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Jinyu Brucella Melitensis Vaccine Product Portfolio
  6. 8.1.5 Jinyu Recent Developments
  7. 8.2 VETAL Animal Health Products Inc.
  8. 8.2.1 VETAL Animal Health Products Inc. Company Information
  9. 8.2.2 VETAL Animal Health Products Inc. Business Overview
  10. 8.2.3 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product Portfolio
  12. 8.2.5 VETAL Animal Health Products Inc. Recent Developments
  13. 8.3 Onderstepoort
  14. 8.3.1 Onderstepoort Company Information
  15. 8.3.2 Onderstepoort Business Overview
  16. 8.3.3 Onderstepoort Brucella Melitensis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Onderstepoort Brucella Melitensis Vaccine Product Portfolio
  18. 8.3.5 Onderstepoort Recent Developments
  19. 8.4 MSD Animal Health
  20. 8.4.1 MSD Animal Health Company Information
  21. 8.4.2 MSD Animal Health Business Overview
  22. 8.4.3 MSD Animal Health Brucella Melitensis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MSD Animal Health Brucella Melitensis Vaccine Product Portfolio
  24. 8.4.5 MSD Animal Health Recent Developments
  25. 8.5 JOVAC
  26. 8.5.1 JOVAC Company Information
  27. 8.5.2 JOVAC Business Overview
  28. 8.5.3 JOVAC Brucella Melitensis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 JOVAC Brucella Melitensis Vaccine Product Portfolio
  30. 8.5.5 JOVAC Recent Developments
  31. 8.6 Hester Biosciences Limited
  32. 8.6.1 Hester Biosciences Limited Company Information
  33. 8.6.2 Hester Biosciences Limited Business Overview
  34. 8.6.3 Hester Biosciences Limited Brucella Melitensis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hester Biosciences Limited Brucella Melitensis Vaccine Product Portfolio
  36. 8.6.5 Hester Biosciences Limited Recent Developments
  37. 8.7 Dollvet
  38. 8.7.1 Dollvet Company Information
  39. 8.7.2 Dollvet Business Overview
  40. 8.7.3 Dollvet Brucella Melitensis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dollvet Brucella Melitensis Vaccine Product Portfolio
  42. 8.7.5 Dollvet Recent Developments
  43. 8.8 CZ Veterinaria
  44. 8.8.1 CZ Veterinaria Company Information
  45. 8.8.2 CZ Veterinaria Business Overview
  46. 8.8.3 CZ Veterinaria Brucella Melitensis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CZ Veterinaria Brucella Melitensis Vaccine Product Portfolio
  48. 8.8.5 CZ Veterinaria Recent Developments
  49. 8.9 Antigen
  50. 8.9.1 Antigen Company Information
  51. 8.9.2 Antigen Business Overview
  52. 8.9.3 Antigen Brucella Melitensis Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Antigen Brucella Melitensis Vaccine Product Portfolio
  54. 8.9.5 Antigen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Brucella Melitensis Vaccine Value Chain Analysis
  2. 9.1.1 Brucella Melitensis Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Brucella Melitensis Vaccine Production Mode & Process
  6. 9.2 Brucella Melitensis Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Brucella Melitensis Vaccine Distributors
  9. 9.2.3 Brucella Melitensis Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst